RACHEL SHAPIRO: Open Payments
NPI 1720488836 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 38 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $204 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $228 |
| Sumitomo Pharma America, Inc. | 8 | $202 |
| COLOPLAST CORP | 11 | $194 |
| ABBVIE INC. | 6 | $148 |
| ConvaTec Inc. | 2 | $72 |
| Cycle Pharmaceuticals Inc | 2 | $60 |
| Procept Biorobotics Corporation | 1 | $46 |
| 180 Medical, Inc. | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $14 |
Products named: INTERSTIM, GEMTESA, Luja Coude, BOTOX, GENTLECATH GLIDE, Sajazir, AQUABEAM ROBOTIC SYSTEM, SpeediCath.
Industry payments across CA — which companies pay providers there.
